Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Supportive Care 1 Signs and Symptoms 1 Sepsis 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Pain 1 Menstruation Disturbances 1 Lymphoma 1 Lung Neoplasms 1 Insulin Resistance 1 Hyperandrogenism 1 Hot Flashes 1 Facies 1 Breast Neoplasms 1 Anxiety Disorders 1 Anatomic Stage I Breast Cancer AJCC v8 1 Agnosia 1

Interventions

Cyclophosphamide 27 fludarabine 18 Rituximab 17 obinutuzumab 11 venetoclax 9 Bendamustine Hydrochloride 9 Lenalidomide 8 zanubrutinib 6 Prednisone 6 Doxorubicin 6 Blood Specimen Collection 6 pembrolizumab 5 fludarabine phosphate 5 Biopsy 5 ibrutinib 4 glofitamab 4 Vincristine 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 Exercise 4 loncastuximab tesirine 3 gamma-Globulins 3 axicabtagene ciloleucel 3 acalabrutinib 3 Temozolomide 3 Surveys and Questionnaires 3 Palliative Care 3 Mycophenolic Acid 3 Methotrexate 3 Mesna 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Acupuncture Therapy × Clear all

NCT05982223 2023-08-08

Integrative Medicine in Lymphoma Survivors

Bnai Zion Medical Center

Phase NA Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡